Rate My Professor William Chan

William Chan serves as Adjunct Lecturer at Monash University within the Faculty of Medicine, Nursing and Health Sciences and Professor of Medicine at the University of Melbourne. He earned his MBBS with Honours from the University of Melbourne in 2001, followed by FRACP in 2008, a PhD from Monash University in 2011 focused on acute myocardial infarction, peripheral arterial disease, and novel cardiac magnetic resonance imaging applications, and FCSANZ. His training encompassed undergraduate studies and advanced cardiology at the Royal Melbourne Hospital, PhD research at The Alfred and Baker IDI Heart and Diabetes Institute, and three years of postdoctoral clinical training and research at Mount Sinai and Toronto General Hospitals in Canada. Currently, he is a consultant interventional cardiologist at The Alfred, Western, and Sunshine Hospitals, heading the Cardiac Catheterisation Laboratories at Western Health, leading the Interventional Services Program, and co-founding the Western Health Cardiogenic Shock Initiative, the first in Victoria for streamlining care in cardiogenic shock from severe heart attacks.

Chan's research specializations include complex high-risk coronary artery revascularization for heart failure patients unsuitable for bypass surgery due to comorbidities like advanced age or severe heart weakness, encompassing unprotected left main stenting, rotational atherectomy for calcified vessels, complex bifurcation lesions, mechanical circulatory support, and chronic total occlusions. He also addresses hypertrophic cardiomyopathy through catheter-based alcohol septal ablation to alleviate symptoms. A recipient of the NHMRC Early Career Fellowship and the 2011 Cardiac Society of Australia and New Zealand Clinical Ralph Reader Prize for Young Investigator, he supervises PhD fellows, basic physician trainees, cardiology advanced trainees, and medical students. Key publications feature "Clinical outcomes of cardiogenic shock among critically ill patients admitted to intensive care units in Australia and New Zealand from 2003 to 2022" (2025, Journal of Critical Care), "Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival" (2025, European Heart Journal), "Development of an Acute Coronary Syndrome-Cardiogenic Shock Risk Score for 30-day Mortality From the Victorian Cardiac Outcomes Registry" (2025, Catheterization and Cardiovascular Interventions), and "Protocolised Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock in Australia" (2025, Catheterization and Cardiovascular Interventions). With over 90 research outputs, his contributions advance outcomes in acute coronary syndromes, cardiogenic shock, and interventional cardiology.